Does Fosamax Increase the Risk of Esophageal Cancer?
Federal regulators are trying to determine whether Fosamax and other bisphosphonates drugs may up the risk of esophageal cancer. The Food and Drug Administration says a review has been launched into this matter. If you believe that you or someone you love is suffering serious health issues and that this may be a result of taking a bisphosphonate drug, contact our Los Angeles Fosamax drug law firm today.
Right now, there is conflicting information about whether this may be the case. One study, from the U.K. General Practice Research Database, said that taking oral bisphosphonates for over 3 years (or for more than 10 prescriptions) doubled the risk of esophageal cancer. Meantime, other studies show that these drugs do not increase the risk of cancer and may even decrease it.
Oral bisphosphonates have, however, been known to cause esophageal ulcers and inflammation--especially when used incorrectly. These side effects can be possible precursors for cancer.
Esophageal Cancer
This cancer affects the esophagus, which is the tube that transports food from the mouth to the stomach. Esophageal cancer is typically not curable. Treatment--if the cancer hasn't spread elsewhere--can improve chances of survival. If the cancer has spread, then treatment can help relieve symptoms, which may include backwards movement of food through the esophagus, chest pain, problems swallowing, vomiting of blood, heartburn, and severe weight loss.
Fosamax, Boniva, Actonel, Atelvia, Skelid, and Didronel are among the medications that the FDA is looking at to see whether there is a link to esophageal cancer. These medications are taken to treat osteoporosis.
Fosamax Lawsuits
Fosamax is already linked to serious jaw problems and femur fractures. These health complications have resulted in hundreds of dangerous drug lawsuits against pharmaceutical company Merck alleging products liability.
Our Anaheim dangerous drug lawyers represent patients who have suffered serious health complications or injuries from taking medications that were not safe for them to use or whose manufacturers failed to warn about the risks.
FDA Studying Link Between Bisphosphonates, Esophageal Cancer, Medscape, July 21, 2011
FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk, Bloomberg, July 21, 2011
Esophageal Cancer Symptoms, Mayo Clinic
Related Web Resources:
FDA
More Blog Posts:
Federal Fosamax Lawsuits Over Femur Fractures to be Coordinated Under Multidistrict Litigation, California Injury Lawyers Blog, July 29, 2011
Fosamax: FDA to Form Advisory Committee to Explore Benefits and Risks of Long-Term Bisphosphonate Treatment of Osteoporosis, California Injury Lawyers Blog, July 24, 2011
Fosamax Lawsuit: Retired Teacher Sues Merck After She Breaks Her Thigh Bone, California Injury Lawyers Blog, June 30, 2011